Google Chrome
Safari
Firefox
Edge
Press Release / May 27, 2021
Hovione and iBET announce strategic collaboration
A strategic partnership that will take Hovione to new technology frontiers.
Search
Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Corticosteroids
Corticosteroids are produced in two dedicated buildings on the Loures site, which are equipped with vessels ranging from 50L up to 4000L.
Press Release / Nov 11, 2021
Hovione invests $170 million in new capacity and capabilities
Hovione, the global leader in spray drying and particle engineering, today announced that it is expanding its industrial facilities around the world to support its ambitious growth objectives
Drug Substance Development
Hovione designs smarter, safer, and more efficient API processes—built on science, strengthened by data, enriched by experience, and ready for scale—helping you move faster, control complexity, and bring your product to market with confidence.
Press Release / Mar 07, 2024
Hovione partners with Dragonfly Technologies to offer micellar chemistry technology to customers as a sustainable alternative to conventional chemical processes
The agreement provides Hovione with the capability to develop chemistry-in-water, enabling a significant reduction in carbon footprint compared to conventional chemical processes relying on traditional organic solvents.
Hydrogenations
Hovione has vast experience in developing hydrogenation processes using both heterogeneous and homogeneous catalysis.
Article / Jan 02, 2020
Fresh Thinking in Biologic Drug Formulation
Pharmaceutical Technology, 02 January 2020